Mouse models of blood-stage malaria infections: Immune responses and cytokines involved in protection and pathology

Chemical Immunology

Volumn 80, Issue , 2002, Pages 204-228

  Langhorne, Jean ^a   Quin, Stuart J ^a   Sanni, Latifu A ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LYMPHOTOXIN; NITRIC OXIDE; PARASITE ANTIGEN; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; ANTIGENIC VARIATION; BLOOD; BRAIN MALARIA; CELL PROTECTION; CYTOKINE PRODUCTION; HYPOGLYCEMIA; IMMUNE RESPONSE; INFECTION SENSITIVITY; MALARIA; MOUSE; NONHUMAN; PARASITE DEVELOPMENT; PATHOLOGY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

EID: 0036095711     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058845     Document Type: Review

References (145)

1. Antigenic variation in Plasmodium falciparum: Mechanisms and consequences
2. Host parasite interaction and morbidity in malaria endemic areas
3. World Health Organization: Severe and complicated malaria
4. World Health Organization: Severe and complicated malaria
5. Tumor necrosis factor and disease severity in children with Falciparum malaria
6. TNF concentrations in fatal cerebral, non-fatal cerebral and uncomplicated Plasmodium falciparum malaria
7. Circulating 1CAM-1 levels in falciparum malaria are high but unrelated to disease severity
8. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and non-cerebral malaria
9. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria
10. A defect in IL-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection
11. Immune effector mechanisms in malaria
12. The role of intrahepatic lymphocytes in mediating protective immunity induced by attenuated Plasmodium berghei sporozoites
13. Roles of CD4- and CD8-bearing T lymphocytes in the immune response to the crythrocytic stages of Plasmodium chabaudi
14. CD4+ and CD8+ T lymphocytes both contribute to acquired immunity to blood-stage Plasmodium chabaudi (AS)
15. CD4+ T cells and B cells are necessary for the transfer of protective immunity to Plasmodium chabaudi chabaudi
16. αβ and γδ T cells in the immune response to the erythrocytic stages of malaria in mice
17. Cellular mechanisms in immunity to blood stage infection
18. Absolute requirement for an active immune response involving B cells and Th cells in immunity to Plasmodium yoelii passively acquired with antibodies to the 19-kDa carboxyl-terminal fragment of merozoite surface protein-1
19. γδ cells function in cell mediated immunity to acute blood stage
20. Low CD4+ T cell responses to the C-terminal region of the malaria merozoite surface protein-1 may be attributed to processing within distinct MHC class II pathways
21. Capture and processing of exogenous antigens for presentation on MHC molecules
22. Macrophage activation during Plasmodium chabaudi AS infection in resistant C57B1/6 and susceptible A/J mice
23. Deletion of Plasmodium berghei-specific CD4+ T cells adoptively transferred into recipient mice after challenge with homologous parasite
24. Induction of Th2 and Th2 CD4+ T cell response: The alternative approaches
25. Antibody independent mechanisms in development of acquired immunity to malaria
26. Immunity to P. chabaudi adami in the T-cell deficient mouse
27. Gene-targeted mice lacking B cells are unable to eliminate a blood stage malaria infection
28. Frequencies of CD4 T cells reactive with Plasmodium chabaudi chabaudi: Distinct response kinetics for cells with Th1 and Th2 characteristics during infection
29. Limiting dilution analysis of the T cell response to Plasmodium chabaudi chabaudi in mice
30. The role of Th1 and Th2 cells in a rodent malaria infection
31. Cellular mechanisms in the immune response to malaria in Plasmodium vinckei-infected mice
32. Interleukin 12 and its role in the generation of Th1 cells
33. In vivo IL-12 production and IL-12 receptors β1 and β2 mRNA expression in the spleen are differentially up-regulated in resistant B6 and susceptible A/J mice during early blood-stage Plasmodium chabaudi (AS) malaria
34. IL-12 induced protection against blood-stage Plasmodium chabaudi (AS) requires IFN-γ and TNF and occurs via a nitric oxide dependent mechanism
35. Plasmodium chabaudi chabaudi (AS): Inflammatory cytokines and pathology in an erythrocytic-stage infection in mice
36. Role of interferon-gamma and tumour necrosis factor in host resistance to Plasmodium chabaudi (AS)
37. The course of Plasmodium chabaudi chabaudi infections in interferon gamma receptor deficient mice
38. Role of gamma interferon during infection with Plasmodium chabaudi chabaudi
39. Human peripheral blood γδ T cells respond to antigens of Plasmodium falciparum
40. Phenotypic characterisation of splenic T cells from mice infected with Plasmodium chabaudi chabaudi
41. Expansion of the CD4-, CD8-γδ T cell subset in the spleens of mice during non-lethal blood-stage malaria
42. γδ T cells contribute to control of chronic parasitemia in Plasmodium chabaudi infections in mice
43. Quantitative analysis of the response of human T cell receptor Vγ9+ cells to Plasmodium filciparum
44. The response of γδ T cells to Plasmodium falciparum is dependent on activated CD4 T cells and the recognition of MHC class I molecules
45. Cytokine profiles for human Vγ9+ T cells stimulated by Plasmodium falciparum
46. Inhibition of Plasmodium falciparum in vitro by human γδ T cells
47. Possible roles of tumor necrosis factor in the pathology of malaria
48. Human recombinant tumor necrosis factor alpha protects susceptible A/J mice against lethal Plasmodium chabaudi (AS) infection
49. Deficiency in tumor necrosis factor alpha activity does not impair early protective Th1 responses against blood-stage malaria
50. Killing of Plasmodium falciparum in vitro by nitric oxide derivatives
51. Altered immune response in mice lacking inducible nitric oxide synthase
52. Parasite killing in murine malaria does not require nitric oxide production
53. Differential induction of helper T cell subsets during blood-stage Plasmodium chabaudi (AS) infection in resistant and susceptible mice
54. The immune response to Plasmodium chabaudi malaria in interleukin-4-deficient mice
55. The time course of selected malarial infections in cytokine deficient mice
56. Plasmodium chabaudi chabaudi: Differential susceptibility of gene-targeted mice deficient in IL-10 to an erythrocytic-stage infection
57. Altered response of CD4+ T cell subsets to Plasmodium chabaudi chabaudi in B cell-deficient mice
58. B cells are required for the switch from Th1- to Th2-regulated immune responses to Plasmodium chabaudi chabaudi infection
59. A role for B cells in the development of T cell helper function in a malaria infection in mice
60. The resolution of acute malaria in a definitive model of B cell deficiency, the JHD mouse
61. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells
62. Cutting edge: The IgG response to the circumsporozoite proteins is MHC class II-dependent and CD1d-independent: Exploring the role of GPIs in NK T cell activation and antimalarial responses
63. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes
64. The immunological response of CBA mice to P. yoelii. II. The passive transfer of immunity with serum and cells
65. Antimalarial antibodies of the immunoglobulin G2a isotype modulate parasitaemias in mice infected with Plasmodium yoelii
66. Interferon-gamma and the induction of protective IgG2a antibodies in non-lethal Plasmodium berghei infections of mice
67. Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages
68. Human antibody response to Plasmodium falciparum merozoite surface protein 2 is serogroup specific and predominantly of the immunoglobulin G3 subclass
69. Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model
70. The mechanism of antibody-mediated protection in Plasmodium yoelii infection
71. Immunoglobulin G3 antibodies specific for the 19kDa carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein 1 transfer protection to mice deficient in Fc-gamma R1 receptors
72. Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein
73. Distinct dendritic cell subset differentially regulate the class of immune response in vivo
74. The control of T cell responses by dendritic subsets
75. Transforming growth factor β production is inversely correlated with severity of murine malaria infection
76. Reciprocal regulation of Th1- and Th2-cytokine-producing T cells during clearance of parasitemia in Plasmodium falciparum malaria
77. A longitudinal study of naturally acquired cellular and humoral immune responses to a merozoite surface protein (MSP) of Plasmodium falciparum in an area of seasonal malaria transmission
78. Elevated plasma levels of 1gE in Plasmodium falciparum-primed individuals reflect an increased ratio of IL-4 to interferon gamma (IFN-gamma)-producing cells
79. Differential immunoglobulin E and cytokine responses in BALB/c and C57B1/6 mice during repeated infections with blood stage Plasmodium chabaudi malaria
80. Altered immune responses in mice with concomitant Schistosoma mansoni and Plasmodium chabaudi infections
81. Immunity to malaria: Antigenic variation in chronic infections of Plasmodium knowlesi
82. Antigenic variation during malaria infection: The contribution from the murine parasite Plasmodium chabaudi
83. A rhoptry-protein-associated mechanism of clonal phenotypic variation in rodent malaria
84. Rapid switching to multiple antigenic and adhesive phenotypes in malaria
85. Malaria: Current and future prospects for control 1
86. Malaria and the nervous system
87. Prognostic risk factors and post mortem findings in cerebral malaria in children
88. Cerebral malaria
89. Seizures and status epilepticus in childhood cerebral malaria
90. Profiles of cytokine production in relation with susceptibility to cerebral malaria
91. Are reactive oxygen species involved in the pathogenesis of murine cerebral malaria?
92. Pathology of fatal and resolving Plasmodium berghei cerebral malaria in mice
93. Cerebral malaria in inbred mice. I. A new model and its pathology
94. Ultrastructural changes in the blood-brain barrier of mice infected with Plasmodium berghei
95. Early microvascular changes in murine cerebral malaria detected in retinal wholemounts
96. Microvascular hemodynamics and in vivo evidence for the role of intercellular adhesion molecule-1 in the sequestration of infected red blood cells in a mouse model of lethal malaria
97. Cerebral malaria in mice: Demonstration of cytoadherence of infected red blood cells and microrheologic correlates
98. Brain capillary blockage produced by a virulent strain of rodent malaria
99. L3T4+ T-lymphocytes play a major role in the pathogenesis of murine cerebral malaria
100. Murine AIDS protects mice against experimental cerebral malaria: Down-regulation by interleukin 10 of a T-helper type 1 CD4+ cell-mediated pathology
101. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria
102. Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria
103. TNF and Plasmodium berghei ANKA-induced cerebral malaria
104. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria
105. The pathophysiology of malaria
106. Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria
107. Interleukin-10 modulates susceptibility in experimental cerebral malaria
108. Differential cellular accumulation of transforming growth factor-β1, β2, and -β3 in brains of patients who died of cerebral malaria
109. The importance of anaemia in cerebral and uncomplicated falciparum malaria: Role of complications, dyserythropoiesis and iron sequestration
110. Malaria is an important cause of anaemia in primigravidae: Evidence from a district hospital in coastal Kenya
111. Haematological manifestation of systemic diseases in children of the third world
112. Tumor necrosis factor alpha and the anemia associated with murine malaria
113. The anaemia of P.falciparum malaria
114. The immunological response of CBA mice to P.yoelii. I. General characteristics, the effects of T-cell deprivation and reconstitution with thymus grafts
115. Murine malaria: Genetic control of resistance to Plasmodium chabaudi
116. Possible roles of tumor necrosis factor in the pathology of malaria
117. Murine malaria decreases hemopoietic stem cells
118. Tumor necrosis factor-alpha and hematopoietic progenitors: Effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells
119. Tumour necrosis factor may contribute to the anaemia of malaria by causing dyserythropoiesis and erythrophagocytosis
120. Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice
121. Anaemia and resistance to malaria in transgenic mice expressing human tumour necrosis factor
122. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles
123. A low interleukin-10 tumor necrosis factor-a ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya
124. Low plasma concentration of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria
125. Childhood coma in Ibadan. Relationship to socio-economic factors
126. Hypoglycaemia and counter-regulatory hormone responses in severe falciparum malaria: Treatment with Sandostatin
127. The biological basis of malarial disease
128. Incidence of hypoglycaemia in children with severe Plasmodium falciparum malaria around Rourkela, Orissa state
129. Lactic acidosis and hypoglycaemia in children with severe malaria: Pathophysiological and prognostic significance
130. Reversal of hypoglycaemia in murine malaria by drugs that inhibit insulin secretion
131. Malaria, blood glucose, and the role of tumour necrosis factor (TNF) in mice
132. Blood-stage malaria infection in diabetic mice
133. Tumor necrosis factor and interleukin-1 synergy in the context of malaria pathology
134. Mechanisms of TNF-alpha-induced insulin resistance
135. Is ischemia involved in the pathogenesis of murine cerebral malaria?
136. Early gamma interferon responses in lethal and nonlethal murine blood-stage malaria
137. Genetic control of blood parasitaemia in mouse malaria maps to chromosome 8
138. Mouse loci for malaria-induced mortality and the control of parasitaemia
139. Temporal expression of an H-2 inbred locus in host response to mouse malaria
140. A Th1-associated increase in tumor necrosis factor alpha expression in the spleen correlates with resistance to blood-stage malaria in mice
141. Rodent malarias: The mouse as a model for understanding immune responses and pathology induced by the erythrocytic stages of the parasite
142. Direct activation of dendritic cells by the malaria parasite, Plasmodium chabaudi chabaudi
143. Tumor necrosis factor alpha p55 receptor is important for development of memory responses to blood-stage malaria infection
144. Complement contributes to protective immunity against reinfection by Plasmodium chabaudi chabaudi parasites